Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 3471

1.

D-loop Mutations in Renal Cell Carcinoma Improve Predictive Accuracy for Cancer-Related Death by Integrating with Mutations in the NADH Dehydrogenase Subunit 1 Gene.

Kim H, Komiyama T, Nitta M, Kawamura Y, Hasegawa M, Shoji S, Orihashi Y, Inomoto C, Kajiwara H, Nakamura N, Kobayashi H, Miyajima A.

Genes (Basel). 2019 Dec 2;10(12). pii: E998. doi: 10.3390/genes10120998.

2.

High-Pressure Synthesis and Crystal Structure of MoC-Type Tungsten Nitride by Nitridation with Ammonium Chloride.

Sasaki T, Ikoma T, Sago K, Liu Z, Niwa K, Ohsuna T, Hasegawa M.

Inorg Chem. 2019 Dec 3. doi: 10.1021/acs.inorgchem.9b01945. [Epub ahead of print]

PMID:
31793774
3.

Corrigendum to 'Prosthesis Used in Microvascular Decompressions: A Multicenter Survey in Japan Focusing on Adverse Events' [World Neurosurgery 130 (2019) e251-e258].

Hasegawa M, Hatayama T, Kondo A, Nagahiro S, Fujimaki T, Amagasaki K, Arita K, Date I, Fujii Y, Goto T, Hanaya R, Higuchi Y, Hongo K, Inoue T, Kasuya H, Kayama T, Kawashima M, Kohmura E, Maehara T, Matsushima T, Mizobuchi Y, Morita A, Nishizawa S, Noro S, Saito S, Shimano H, Shirane R, Takeshima H, Tanaka Y, Tanabe H, Toda H, Yamakami I, Nishiyama Y, Ohba S, Hirose Y, Suzuki T.

World Neurosurg. 2019 Nov 13. pii: S1878-8750(19)32700-7. doi: 10.1016/j.wneu.2019.10.081. [Epub ahead of print] No abstract available.

PMID:
31780425
4.

The POLARBEAR Fourier transform spectrometer calibrator and spectroscopic characterization of the POLARBEAR instrument.

Matsuda F, Lowry L, Suzuki A, Aguilar Fáundez M, Arnold K, Barron D, Bianchini F, Cheung K, Chinone Y, Elleflot T, Fabbian G, Goeckner-Wald N, Hasegawa M, Kaneko D, Katayama N, Keating B, Lee AT, Navaroli M, Nishino H, Paar H, Puglisi G, Richards PL, Seibert J, Siritanasak P, Tajima O, Takatori S, Tsai C, Westbrook B.

Rev Sci Instrum. 2019 Nov 1;90(11):115115. doi: 10.1063/1.5095160.

PMID:
31779409
5.

Benefit-risk assessment of nivolumab 240 mg flat dose relative to 3 mg/kg Q2W regimen in Japanese patients with advanced cancers.

Bei D, Osawa M, Uemura S, Ohno T, Gobburu J, Roy A, Hasegawa M.

Cancer Sci. 2019 Nov 26. doi: 10.1111/cas.14252. [Epub ahead of print]

6.

[A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in an elderly woman].

Matsumoto S, Nishihara K, Hasegawa M, Satake S, Endo H, Arai H.

Nihon Ronen Igakkai Zasshi. 2019;56(4):525-531. doi: 10.3143/geriatrics.56.525. Japanese.

7.

Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer.

Nakai Y, Tanaka N, Asakawa I, Torimoto K, Miyake M, Anai S, Fujii T, Hasegawa M, Fujimoto K.

J Contemp Brachytherapy. 2019 Oct;11(5):409-416. doi: 10.5114/jcb.2019.88142. Epub 2019 Oct 30.

8.

Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population.

Yokoyama N, Kawasaki A, Matsushita T, Furukawa H, Kondo Y, Hirano F, Sada KE, Matsumoto I, Kusaoi M, Amano H, Nagaoka S, Setoguchi K, Nagai T, Shimada K, Sugii S, Hashimoto A, Matsui T, Okamoto A, Chiba N, Suematsu E, Ohno S, Katayama M, Migita K, Kono H, Hasegawa M, Kobayashi S, Yamada H, Nagasaka K, Sugihara T, Yamagata K, Ozaki S, Tamura N, Takasaki Y, Hashimoto H, Makino H, Arimura Y, Harigai M, Sato S, Sumida T, Tohma S, Takehara K, Tsuchiya N.

Sci Rep. 2019 Nov 8;9(1):16366. doi: 10.1038/s41598-019-52920-0.

9.

Prion-like propagation of α-synuclein in neurodegenerative diseases.

Tarutani A, Hasegawa M.

Prog Mol Biol Transl Sci. 2019;168:323-348. doi: 10.1016/bs.pmbts.2019.07.005. Epub 2019 Jul 31.

PMID:
31699325
10.

Five-year cumulative incidence of overweight and obesity, and longitudinal change in body mass index in Japanese workers: The Japan Epidemiology Collaboration on Occupational Health Study.

Hasegawa M, Akter S, Hu H, Kashino I, Kuwahara K, Okazaki H, Sasaki N, Ogasawara T, Eguchi M, Kochi T, Miyamoto T, Nakagawa T, Honda T, Yamamoto S, Murakami T, Shimizu M, Uehara A, Yamamoto M, Imai T, Nishihara A, Tomita K, Nagahama S, Hori A, Konishi M, Kabe I, Mizoue T, Kunugita N, Dohi S; Japan Epidemiology Collaboration on Occupational Health Study Group.

J Occup Health. 2019 Nov 2. doi: 10.1002/1348-9585.12095. [Epub ahead of print]

11.

Prognosis of pulmonary fibrosis presenting with a usual interstitial pneumonia pattern on computed tomography in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis: a retrospective single-center study.

Watanabe T, Minezawa T, Hasegawa M, Goto Y, Okamura T, Sakakibara Y, Niwa Y, Kato A, Hayashi M, Isogai S, Kondo M, Yamamoto N, Hashimoto N, Imaizumi K.

BMC Pulm Med. 2019 Nov 1;19(1):194. doi: 10.1186/s12890-019-0969-5.

12.

Homeostatic Function of Dermokine in the Skin Barrier and Inflammation.

Utsunomiya A, Chino T, Utsunomiya N, Luong VH, Tokuriki A, Naganuma T, Arita M, Higashi K, Saito K, Suzuki N, Ohara A, Sugai M, Sugawara K, Tsuruta D, Oyama N, Hasegawa M.

J Invest Dermatol. 2019 Oct 15. pii: S0022-202X(19)33303-2. doi: 10.1016/j.jid.2019.09.011. [Epub ahead of print]

PMID:
31669414
13.

Prostate-specific antigen bounce after 125I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosterone.

Nakai Y, Tanaka N, Asakawa I, Anai S, Miyake M, Morizawa Y, Hori S, Owari T, Fujii T, Yamaki K, Hasegawa M, Fujimoto K.

Jpn J Clin Oncol. 2019 Oct 28. pii: hyz136. doi: 10.1093/jjco/hyz136. [Epub ahead of print]

PMID:
31665354
14.

Tau progression in single severe frontal traumatic brain injury in human brains.

Okamura Y, Kawakami I, Watanabe K, Oshima K, Niizato K, Ikeda K, Akiyama H, Hasegawa M.

J Neurol Sci. 2019 Dec 15;407:116495. doi: 10.1016/j.jns.2019.116495. Epub 2019 Oct 9.

PMID:
31655411
15.

Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology.

Hayakawa H, Nakatani R, Ikenaka K, Aguirre C, Choong CJ, Tsuda H, Nagano S, Koike M, Ikeuchi T, Hasegawa M, Papa SM, Nagai Y, Mochizuki H, Baba K.

Mov Disord. 2019 Oct 23. doi: 10.1002/mds.27887. [Epub ahead of print]

PMID:
31643109
16.

The Wnt/Ca2+ pathway is involved in interneuronal communication mediated by tunneling nanotubes.

Vargas JY, Loria F, Wu YJ, Córdova G, Nonaka T, Bellow S, Syan S, Hasegawa M, van Woerden GM, Trollet C, Zurzolo C.

EMBO J. 2019 Dec 2;38(23):e101230. doi: 10.15252/embj.2018101230. Epub 2019 Oct 18.

PMID:
31625188
17.

[The accuracy of noninvasive total hemoglobin measurement in critically ill patients].

Oishi R, Hasegawa M, Hakozaki T, Obara S, Isosu T, Murakawa M.

Rev Bras Anestesiol. 2019 Sep - Oct;69(5):527-528. doi: 10.1016/j.bjan.2019.05.003. Epub 2019 Oct 14. Portuguese. No abstract available.

18.

Effect of neoadjuvant chemotherapy in patients undergoing radical cystectomy for muscle-invasive bladder cancer: a retrospective, multi-institutional study.

Nitta M, Kuroda S, Nagao K, Higure T, Zakoji H, Miyakita H, Usui Y, Hasegawa M, Kawamura Y, Shoji S, Miyajima A.

Jpn J Clin Oncol. 2019 Oct 15. pii: hyz137. doi: 10.1093/jjco/hyz137. [Epub ahead of print]

PMID:
31612911
19.

Mutations in CHCHD2 cause α-synuclein aggregation.

Ikeda A, Nishioka K, Meng H, Takanashi M, Inoshita T, Shiba-Fukushima K, Li Y, Yoshino H, Mori A, Okuzumi A, Yamaguchi A, Nonaka R, Izawa N, Ishikawa KI, Saiki H, Morita M, Hasegawa M, Hasegawa K, Elahi M, Funayama M, Okano H, Akamatsu W, Imai Y, Hattori N.

Hum Mol Genet. 2019 Oct 10. pii: ddz241. doi: 10.1093/hmg/ddz241. [Epub ahead of print]

PMID:
31600778
20.

Successful treatment of acquired reactive perforating collagenosis with topical benzoyl peroxide: A possible therapeutic action underlying structural and metabolic turnover.

Miyanaga M, Oyama N, Sakai Y, Imamura Y, Hasegawa M.

J Dermatol. 2019 Oct 9. doi: 10.1111/1346-8138.15102. [Epub ahead of print] No abstract available.

PMID:
31599039
21.

A Functional Parathyroid Cyst from the Hemorrhagic Degeneration of a Parathyroid Adenoma.

Uehara A, Suzuki T, Yamamoto Y, Hasegawa M, Koitabashi K, Yazawa M, Koike J, Shibagaki Y.

Intern Med. 2019 Oct 7. doi: 10.2169/internalmedicine.3319-19. [Epub ahead of print]

22.

Lanthanide-Oligomeric Brush Films: From Luminescence Properties to Structure Resolution.

Marets N, Kanno S, Ogata S, Ishii A, Kawaguchi S, Hasegawa M.

ACS Omega. 2019 Sep 12;4(13):15512-15520. doi: 10.1021/acsomega.9b01775. eCollection 2019 Sep 24.

23.

Synthesis and chiroptical properties of stereogenic cyclic dimers based on 2,2'-biselenophene and [2.2]paracyclophane.

Hasegawa M, Kobayakawa K, Nojima Y, Mazaki Y.

Org Biomol Chem. 2019 Oct 9;17(39):8822-8826. doi: 10.1039/c9ob01907c.

PMID:
31560349
24.

Simultaneous Laparoscopic Surgery for Bladder Diverticulum and Urachal Remnant: A Case Report.

Murata M, Inui K, Hasegawa M, Ikeda Y, Nakagawa Y, Hara N, Nishiyama T.

Case Rep Urol. 2019 Aug 28;2019:5785189. doi: 10.1155/2019/5785189. eCollection 2019.

25.

The basis of clinicopathological heterogeneity in TDP-43 proteinopathy.

Kawakami I, Arai T, Hasegawa M.

Acta Neuropathol. 2019 Nov;138(5):751-770. doi: 10.1007/s00401-019-02077-x. Epub 2019 Sep 26. Review.

26.

Diagnostic flowchart to estimate the morphology of left descending artery lesions by initial electrocardiogram in ST-elevation myocardial infarction.

Fujii T, Hasegawa M, Nakamura N, Ikari Y.

Ann Noninvasive Electrocardiol. 2019 Sep 25:e12695. doi: 10.1111/anec.12695. [Epub ahead of print]

PMID:
31553117
27.

Low-dose-rate brachytherapy for prostate cancer: A 15-year experience in Japan.

Tanaka N, Asakawa I, Hasegawa M, Fujimoto K.

Int J Urol. 2019 Sep 24. doi: 10.1111/iju.14098. [Epub ahead of print] Review.

PMID:
31549770
28.

Parkinson's disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling.

Mori A, Hatano T, Inoshita T, Shiba-Fukushima K, Koinuma T, Meng H, Kubo SI, Spratt S, Cui C, Yamashita C, Miki Y, Yamamoto K, Hirabayashi T, Murakami M, Takahashi Y, Shindou H, Nonaka T, Hasegawa M, Okuzumi A, Imai Y, Hattori N.

Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20689-20699. doi: 10.1073/pnas.1902958116. Epub 2019 Sep 23.

29.

In vivo activation of PEGylated long circulating lipid nanoparticle to achieve efficient siRNA delivery and target gene knock down in solid tumors.

Sasayama Y, Hasegawa M, Taguchi E, Kubota K, Kuboyama T, Naoi T, Yabuuchi H, Shimai N, Asano M, Tokunaga A, Ishii T, Enokizono J.

J Control Release. 2019 Oct;311-312:245-256. doi: 10.1016/j.jconrel.2019.09.004. Epub 2019 Sep 7.

PMID:
31505222
30.

Enhancer variants associated with Alzheimer's disease affect gene expression via chromatin looping.

Kikuchi M, Hara N, Hasegawa M, Miyashita A, Kuwano R, Ikeuchi T, Nakaya A.

BMC Med Genomics. 2019 Sep 9;12(1):128. doi: 10.1186/s12920-019-0574-8.

31.

Tumors of the Orbit: Case Report and Review of Surgical Corridors and Current Options.

Kannan S, Hasegawa M, Yamada Y, Kawase T, Kato Y.

Asian J Neurosurg. 2019 Jul-Sep;14(3):678-685. doi: 10.4103/ajns.AJNS_51_19. Review.

32.

Human NPCs can degrade α-syn fibrils and transfer them preferentially in a cell contact-dependent manner possibly through TNT-like structures.

Grudina C, Kouroupi G, Nonaka T, Hasegawa M, Matsas R, Zurzolo C.

Neurobiol Dis. 2019 Dec;132:104609. doi: 10.1016/j.nbd.2019.104609. Epub 2019 Sep 5.

33.

Universal Strategy for Efficient Electron Injection into Organic Semiconductors Utilizing Hydrogen Bonds.

Fukagawa H, Hasegawa M, Morii K, Suzuki K, Sasaki T, Shimizu T.

Adv Mater. 2019 Oct;31(43):e1904201. doi: 10.1002/adma.201904201. Epub 2019 Sep 6.

PMID:
31490592
34.

The Outcomes of Pancreatic Transplantation from Pediatric Donors-A Single Institution Experience.

Ito T, Kenmochi T, Aida N, Kurihara K, Kawai A, Suzuki A, Shibata M, Hiratsuka I, Hasegawa M.

J Clin Med. 2019 Sep 4;8(9). pii: E1386. doi: 10.3390/jcm8091386.

35.

Machine learning methods can more efficiently predict prostate cancer compared with prostate-specific antigen density and prostate-specific antigen velocity.

Nitta S, Tsutsumi M, Sakka S, Endo T, Hashimoto K, Hasegawa M, Hayashi T, Kawai K, Nishiyama H.

Prostate Int. 2019 Sep;7(3):114-118. doi: 10.1016/j.prnil.2019.01.001. Epub 2019 Jan 29.

36.

[A case of severe acute flaccid myelitis requiring continuous mechanical ventilation].

Matsuo K, Koga M, Shiraishi M, Hasegawa M, Kanda T, Fukusako T.

Rinsho Shinkeigaku. 2019 Sep 25;59(9):579-583. doi: 10.5692/clinicalneurol.cn-001319. Epub 2019 Aug 30. Japanese.

PMID:
31474644
37.

Successful treatment with oral minocycline in a case with a long-standing idiopathic atrophoderma of Pasini and Pierini: Histopathological comparison with the contralateral normal skin.

Honda M, Oyama N, Uesugi S, Katoh T, Hasegawa M.

J Dermatol. 2019 Dec;46(12):e472-e474. doi: 10.1111/1346-8138.15064. Epub 2019 Aug 28. No abstract available.

PMID:
31463968
38.

Linac-Based Fractionated Stereotactic Radiotherapy with a Micro-Multileaf Collimator for Brainstem Metastasis.

Sugimoto T, Matsuda R, Tamamoto T, Hontsu S, Yamaki K, Miura S, Park YS, Nakase H, Hasegawa M.

World Neurosurg. 2019 Dec;132:e680-e686. doi: 10.1016/j.wneu.2019.08.049. Epub 2019 Aug 21.

PMID:
31442651
39.

Prediction model for cardiovascular events or all-cause mortality in incident dialysis patients.

Inaguma D, Morii D, Kabata D, Yoshida H, Tanaka A, Koshi-Ito E, Takahashi K, Hayashi H, Koide S, Tsuboi N, Hasegawa M, Shintani A, Yuzawa Y.

PLoS One. 2019 Aug 22;14(8):e0221352. doi: 10.1371/journal.pone.0221352. eCollection 2019.

40.

Fracture dislocation of the ankle with posterior tibial tendon entrapment within the tibiofibular interosseous space: A case report.

Sato R, Tsuchida Y, Murakami H, Shirakawa T, Futamura K, Hasegawa M, Suzuki T, Tsuihiji K.

Trauma Case Rep. 2019 Aug 2;23:100235. doi: 10.1016/j.tcr.2019.100235. eCollection 2019 Oct.

41.

YES1 Is a Targetable Oncogene in Cancers Harboring YES1 Gene Amplification.

Hamanaka N, Nakanishi Y, Mizuno T, Horiguchi-Takei K, Akiyama N, Tanimura H, Hasegawa M, Satoh Y, Tachibana Y, Fujii T, Sakata K, Ogasawara K, Ebiike H, Koyano H, Sato H, Ishii N, Mio T.

Cancer Res. 2019 Nov 15;79(22):5734-5745. doi: 10.1158/0008-5472.CAN-18-3376. Epub 2019 Aug 7.

PMID:
31391186
42.

The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions.

Miyake M, Tanaka N, Asakawa I, Owari T, Hori S, Morizawa Y, Nakai Y, Inoue T, Anai S, Torimoto K, Hasegawa M, Fujii T, Konishi N, Fujimoto K.

Prostate Int. 2019 Jun;7(2):47-53. doi: 10.1016/j.prnil.2018.04.005. Epub 2018 May 5.

43.

Metabolism of 3-[5'-deoxy-5'-(dimethylarsinoyl)-β-ribofuranosyloxy]-2-hydroxypropylene glycol in an artificial digestive system.

Hata A, Hasegawa M, Yamauchi T, Otomo Y, Miura M, Yamanaka K, Yamano Y, Fujitani N, Endo G.

Heliyon. 2019 Jul 19;5(7):e02079. doi: 10.1016/j.heliyon.2019.e02079. eCollection 2019 Jul.

44.

Preparation of Lipid Nanodisks Containing Apolipoprotein E-Derived Synthetic Peptides for Biocompatible Delivery Vehicles Targeting Low-Density Lipoprotein Receptor.

Tanaka M, Hasegawa M, Yoshimoto N, Hoshikawa K, Mukai T.

Biol Pharm Bull. 2019;42(8):1376-1383. doi: 10.1248/bpb.b19-00287.

45.

LATE to the PART-y.

Josephs KA, Mackenzie I, Frosch MP, Bigio EH, Neumann M, Arai T, Dugger BN, Ghetti B, Grossman M, Hasegawa M, Herrup K, Holton J, Jellinger K, Lashley T, McAleese KE, Parisi JE, Revesz T, Saito Y, Vonsattel JP, Whitwell JL, Wisniewski T, Hu W.

Brain. 2019 Sep 1;142(9):e47. doi: 10.1093/brain/awz224. No abstract available. Erratum in: Brain. 2019 Dec 1;142(12):e73.

46.

Oral ferrous citrate or ferrous sulfate use during predialysis may reduce serum phosphate level at dialysis initiation
.

Koide S, Inaguma D, Koshi-Ito E, Takahashi K, Hayashi H, Tsuboi N, Hasegawa M, Yuzawa Y.

Clin Nephrol. 2019 Oct;92(4):180-189. doi: 10.5414/CN109610.

PMID:
31347494
47.

Intra-articular injection of rebamipide prevents articular cartilage degeneration in murine post-traumatic osteoarthritis models.

Suzuki Y, Hasegawa M, Matsui Y, Unno H, Iino T, Yoshida T, Sudo A.

Mod Rheumatol. 2019 Jul 24:1-8. doi: 10.1080/14397595.2019.1641912. [Epub ahead of print]

PMID:
31339809
48.

Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II-III gliomas to establish genetic predictors of poor prognosis.

Kuwahara K, Ohba S, Nakae S, Hattori N, Pareira ES, Yamada S, Sasaki H, Abe M, Hasegawa M, Hirose Y.

Brain Tumor Pathol. 2019 Oct;36(4):135-143. doi: 10.1007/s10014-019-00348-9. Epub 2019 Jul 19.

PMID:
31324999
49.

Our experience of repeat laparoscopic liver resection in patients with recurrent hepatocellular carcinoma.

Ogawa H, Nakahira S, Inoue M, Irei T, Hasegawa M, Kato K, Oyama K, Himura H, To T, Maki R, Nishi H, Ohara N, Mikami J, Makari Y, Nakata K, Tsujie M, Fujita J.

Surg Endosc. 2019 Jul 18. doi: 10.1007/s00464-019-06992-8. [Epub ahead of print]

PMID:
31321532
50.

Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report.

Fujita K, Matsubara T, Miyamoto R, Sumikura H, Takeuchi T, Maruyama Saladini K, Kawarai T, Nodera H, Udaka F, Kume K, Morino H, Kawakami H, Hasegawa M, Kaji R, Murayama S, Izumi Y.

BMC Neurol. 2019 Jul 18;19(1):168. doi: 10.1186/s12883-019-1402-7.

Supplemental Content

Loading ...
Support Center